Nurix therapeutics will present trial in progress posters for three clinical programs at the annual meeting of the american society of clinical oncology (asco)

Posters provide background information and trial designs for ongoing clinical studies of wholly-owned nx-2127, detil-0255, and nx-1607 programs posters provide background information and trial designs for ongoing clinical studies of wholly-owned nx-2127, detil-0255, and nx-1607 programs
NRIX Ratings Summary
NRIX Quant Ranking